Promontory Therapeutics
0 followers
Promontory Therapeutics Inc. is a clinical stage pharmaceutical company developing small molecule immunotherapies. The company's lead candidate, PT-112, is a novel chemical entity under clinical development that exhibits a unique combination of properties, including immunogenic cell death as well as... Read more
Org chart
Matthew Price
Co-Founder, Executive VP & COO, Director
Matthew Price
Collapse
Aamena Chaudhry
Senior Director, Drug safety
Elodie Benard, MS, CCRP-PM
Associate Director Of Clinical Operations
Helene Shea
Vice President CMC
Johan Baeck
Executive Vice President and Chief Medical Officer
Mariam Mahbob, CCRP
Clinical Trial Manager
Marie-Therese Hehenberger
Director, CMC & Supply Chain
Tyler Ames
Senior Vice President of Research and Development
Jesse Borgese
Vice President Finance
